- Tytuł:
- Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology February 2021 22(2):267-276
Czasopismo naukowe